Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

$60M Challenge Seeks RNA Bio-Production Network

Gene therapy graphic

A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network

Patent Awarded for Safer Cancer Drug Delivery

Chemotherapy vials

A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients. . . . → Read More: Patent Awarded for Safer Cancer Drug Delivery

Biotechs Partner on Crispr Therapies for Neuro Disorders

Adeno-associated virus

Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders

Plant-Based Material Designed to Replace Plastics

Uses of plant-based material

Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics. . . . → Read More: Plant-Based Material Designed to Replace Plastics

Low Cost Vaccine, Patch Device Produce Immune Responses

Vaccine patch

Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses. . . . → Read More: Low Cost Vaccine, Patch Device Produce Immune Responses

Plant-Based Lipids Developed for mRNA Vaccines

Vesicles

Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines

Moderna Expands Vaccine Research, Mfring in Asia

Syringe and three vials

Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia

New Biotech Developing Synthetic Long-Term RNA

Avak Kahvejian

A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA. . . . → Read More: New Biotech Developing Synthetic Long-Term RNA

Cell Therapy Mfring Company Raises $82M in Venture Funds

T-cells and cancer cells

A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds

Biomanufacturing Materials Company Issues $500M IPO

Wall Street sign

Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering. . . . → Read More: Biomanufacturing Materials Company Issues $500M IPO